Detection rates of clinically significant prostate cancer with Magnetic Resonance Imaging pathway vs TRUS biopsy.

“Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide, counting 1,276,106 new cases and causing...

Targeted fusion biopsy and targeted therapy for comprehensive prostate imaging an The advent of MRI has improved detection rates as it...